These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 11282255)

  • 21. Effect of the haloperidol tetrahydropyridine metabolite 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6- tetrahydropyridine on dopamine receptor and transporter binding. A nonhuman primate 123I-iodobenzamide and 2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane single photon emission computed tomographic study.
    Oliver DW; Dormehl IC; Van der Schyf CJ; Neumeyer JL; Hugo N; Keeve R; Rossouw NT; Müller-Gärtner HW; Castagnoli N
    Arzneimittelforschung; 1997 Jun; 47(6):692-9. PubMed ID: 9239444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The variable number of tandem repeats element in DAT1 regulates in vitro dopamine transporter density.
    VanNess SH; Owens MJ; Kilts CD
    BMC Genet; 2005 Nov; 6():55. PubMed ID: 16309561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unaltered dopamine transporter availability in adult attention deficit hyperactivity disorder.
    van Dyck CH; Quinlan DM; Cretella LM; Staley JK; Malison RT; Baldwin RM; Seibyl JP; Innis RB
    Am J Psychiatry; 2002 Feb; 159(2):309-12. PubMed ID: 11823278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Striatal dopamine transporter availability associated with polymorphisms in the dopamine transporter gene SLC6A3.
    van de Giessen E; de Win MM; Tanck MW; van den Brink W; Baas F; Booij J
    J Nucl Med; 2009 Jan; 50(1):45-52. PubMed ID: 19091889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Striatal uptake of I-123-beta-CIT and I-123-IBZM in patients with extrapyramidal symptoms].
    Bettin S; Kämpfer I; Seese A; Schäfer A; Reuter M; Lössner J; Dietrich J; Wagner A; Knapp WH
    Nuklearmedizin; 1997 Aug; 36(5):167-72. PubMed ID: 9380528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. VNTR polymorphism in the SLC6A3 gene does not influence dopamine transporter availability measured by [18F]FE-PE2I PET or [123I]FP-Cit SPECT.
    Jakobson Mo S; Axelsson J; Stiernman LJ; Larsson A; Af Bjerkén S; Bäckström D; Kellgren TG; Varrone A; Riklund K
    Nucl Med Commun; 2022 Mar; 43(3):247-255. PubMed ID: 34908018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging.
    Pirker W; Asenbaum S; Hauk M; Kandlhofer S; Tauscher J; Willeit M; Neumeister A; Praschak-Rieder N; Angelberger P; Brücke T
    J Nucl Med; 2000 Jan; 41(1):36-44. PubMed ID: 10647603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [123I]beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder.
    Malison RT; McDougle CJ; van Dyck CH; Scahill L; Baldwin RM; Seibyl JP; Price LH; Leckman JF; Innis RB
    Am J Psychiatry; 1995 Sep; 152(9):1359-61. PubMed ID: 7653693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simultaneous SPECT studies of pre- and postsynaptic dopamine binding sites in baboons.
    Dresel SH; Kung MP; Huang XF; Plössl K; Hou C; Meegalla SK; Patselas G; Mu M; Saffer JR; Kung HF
    J Nucl Med; 1999 Apr; 40(4):660-6. PubMed ID: 10210226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crack cocaine users show differences in genotype frequencies of the 3' UTR variable number of tandem repeats of the dopamine transporter gene (DAT1/SLC6A3).
    Stolf AR; Szobot CM; Halpern R; Akutagava-Martins GC; Müller D; Guimaraes LS; Kessler FH; Pechansky F; Roman T
    Neuropsychobiology; 2014; 70(1):44-51. PubMed ID: 25247548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single nucleotide polymorphisms distinguish multiple dopamine transporter alleles in primates: implications for association with attention deficit hyperactivity disorder and other neuropsychiatric disorders.
    Miller GM; De La Garza R; Novak MA; Madras BK
    Mol Psychiatry; 2001 Jan; 6(1):50-8. PubMed ID: 11244485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sex differences in [123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers.
    Staley JK; Krishnan-Sarin S; Zoghbi S; Tamagnan G; Fujita M; Seibyl JP; Maciejewski PK; O'Malley S; Innis RB
    Synapse; 2001 Sep; 41(4):275-84. PubMed ID: 11494398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine transporter gene (DAT1) VNTR polymorphism in major psychiatric disorders: family-based association study in the Bulgarian population.
    Georgieva L; Dimitrova A; Nikolov I; Koleva S; Tsvetkova R; Owen MJ; Toncheva D; Kirov G
    Acta Psychiatr Scand; 2002 May; 105(5):396-9. PubMed ID: 11942948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 123I-beta-CIT and 123I-IBZM-SPECT scanning in levodopa-naive Parkinson's disease.
    Wenning GK; Donnemiller E; Granata R; Riccabona G; Poewe W
    Mov Disord; 1998 May; 13(3):438-45. PubMed ID: 9613734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human dopamine transporter gene: coding region conservation among normal, Tourette's disorder, alcohol dependence and attention-deficit hyperactivity disorder populations.
    Vandenbergh DJ; Thompson MD; Cook EH; Bendahhou E; Nguyen T; Krasowski MD; Zarrabian D; Comings D; Sellers EM; Tyndale RF; George SR; O'Dowd BF; Uhl GR
    Mol Psychiatry; 2000 May; 5(3):283-92. PubMed ID: 10889531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meta-analysis shows schizophrenia is not associated with the 40-base-pair repeat polymorphism of the dopamine transporter gene.
    Gamma F; Faraone SV; Glatt SJ; Yeh YC; Tsuang MT
    Schizophr Res; 2005 Feb; 73(1):55-8. PubMed ID: 15567077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Striatal amphetamine-induced dopamine release in patients with schizotypal personality disorder studied with single photon emission computed tomography and [123I]iodobenzamide.
    Abi-Dargham A; Kegeles LS; Zea-Ponce Y; Mawlawi O; Martinez D; Mitropoulou V; O'Flynn K; Koenigsberg HW; Van Heertum R; Cooper T; Laruelle M; Siever LJ
    Biol Psychiatry; 2004 May; 55(10):1001-6. PubMed ID: 15121484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine transporter gene polymorphism, spect imaging, and levodopa response in patients with Parkinson disease.
    Contin M; Martinelli P; Mochi M; Albani F; Riva R; Scaglione C; Dondi M; Fanti S; Pettinato C; Baruzzi A
    Clin Neuropharmacol; 2004; 27(3):111-5. PubMed ID: 15190232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity.
    Jucaite A; Fernell E; Halldin C; Forssberg H; Farde L
    Biol Psychiatry; 2005 Feb; 57(3):229-38. PubMed ID: 15691523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genotypic association between dopamine transporter gene polymorphisms and schizophrenia.
    Persico AM; Macciardi F
    Am J Med Genet; 1997 Feb; 74(1):53-7. PubMed ID: 9034007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.